Regional News

Global Times: China's silver economy unleashes diversified opportunities, fueling growth of multiple sectors

BEIJING, Sept. 22, 2025 /PRNewswire/ -- China is actively addressing the challenges of an aging population. As the senior population grows and their spending habits evolve, the silver economy is emerging as a driver of economic growth and industrial development. From optimizing consumption patter...

2025-09-22 21:26 1761

Global Times: China's silver economy: innovation, dignity, and shared opportunities

BEIJING, Sept. 22, 2025 /PRNewswire/ -- China's silver economy is not only transforming the lives of its senior citizens but also reshaping the global conversation about how societies should respond to demographic change. With medium-speed growth in per capita consumption, the scale ofChina's sil...

2025-09-22 21:20 1645

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine

Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeuti...

2025-09-22 21:00 2078

Unleash Your Tennis: Aceii One, the AI Hitting Partner That Trains, Teaches, and Competes

HONG KONG, Sept. 22, 2025 /PRNewswire/ -- For tennis players, one of the toughest challenges isn't the sport itself—it's finding the right partner, keeping up consistent practice, and affording quality coaching.Aceii One

2025-09-22 21:00 2088

Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets

* Study confirms the novelty and atomic-level precision of de novo antibody design, including cryo-EM validation on a designed anti-PD-L1 antibody * Findings highlight broad therapeutic applicability across oncology, immune, and metabolic diseases SEOUL, South Korea, Sept. 22, 2025 /PRNewswire...

2025-09-22 21:00 1885

SHEIN Launches Mean Girls Collection Making Fetch Happen for Fall

Discover Iconic Classics Reimagined for Your Hottie Era LOS ANGELES, Sept. 22, 2025 /PRNewswire/ -- Global fashion and lifestyle online retailerSHEIN is stirring up major nostalgia with its latest drop: theMean Girls x SHEIN collection, a bold, pink-powered homage to the ...

2025-09-22 21:00 1925

INPARADISE - Taipei's Skyline Buffet

This autumn, enjoy upgraded signature dishes, available for a limited time until November 15. TAIPEI, Sept. 22, 2025 /PRNewswire/ -- Taipei's popular sky-high buffet brand  "INPARADISE" is elevating its signature dishes! The premium "Abalone Seafood Porridge"、"Sauteed Beef Short Ribs with Diane Sa...

2025-09-22 21:00 1730

Locksley Continues to Strengthen its Position in Paving Pathway to 100% Made in America

Company Reports Exceptional Initial Metallurgical Results for Its US Mojave Project SAN BERNARDINO, Calif, Sept. 22, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it has achieved significant results from initial metallurgical testwork completed by the company on...

2025-09-22 20:10 3189

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

BEIJING, Sept. 22, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious ...

2025-09-22 20:00 3317

Autozi Internet Technology (Global) Ltd. Announces Entry into Material Definitive Agreements

BEIJING, Sept. 22, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) ("Autozi" or the "Company"), an automotive products and services company inChina, today announced that it has entered into material definitive agreements. As previously reported, on February 19, 2025, ...

2025-09-22 18:00 1832

Full-Color AR Glasses Reach an Inflection Point! JBD Teams Up with Applied Materials and RayNeo to Break Through AR Display Quality Bottlenecks

SHANGHAI, Sept. 22, 2025 /PRNewswire/ -- JBD recently announced that their collaboration with RayNeo and Applied Materials, Inc. has achieved a substantial breakthrough in the display quality of full-color waveguide AR glasses. The results are first commercialized in the RayNeo X3 Pro, markedly ...

2025-09-22 16:53 1908

K-Beauty Lives in 2025: IUNIK's Minimalist Beta-Glucan Breakthrough

SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ -- Do you ever feel like you're doing too much for your skin yet still battling dryness? You're not alone. In 2025, many people are discovering that dryness isn't a sign you need a skincare routine with 10 steps, but rather good performance products...

2025-09-22 15:35 1366

Xinjiang's foreign trade makes big leaps in scale and openness

BEIJING, Sept. 22, 2025 /PRNewswire/ -- A news report from chinadaily.com.cn    Xinjiang's foreign trade has made big leaps in its scale and openness, said Li Xuan, a member of the Xinjiang Committee of the Chinese People's Political Consultative Conference (CPPCC) and deputy director-general of ...

2025-09-22 15:28 1322

Govee Launches Permanent Outdoor Lights Prism, Ushering in a New Era of Outdoor Lighting

 As the creator of the category, Govee advances innovation with the industry's first Triple-Color Effect Optics Bellevue, Wash., Sept. 22, 2025 /PRNewswire/ -- Govee , a global leader in smart lighting innovations, today announced the official launch of the Govee Permanent...

2025-09-22 15:05 1518

MediaTek Dimensity 9500 Unleashes Best-in-Class Performance, AI Experiences, and Power Efficiency for the Next Generation of Mobile Devices

New flagship chipset further strengthens industry leadership in gaming, compute, imaging, and AI HSINCHU, Sept. 22, 2025 /PRNewswire/ -- MediaTek, the world's leading innovator of smartphone SoCs, today announced the launch of its most advanced mobile platform yet: The MediaTek Dimensity 9500. S...

2025-09-22 15:00 4540

Akeso Announces First Patient Dosed in Registrational Phase II Study of TIGIT/TGF-β Bifunctional Antibody Fusion Protein AK130 Combined with Ivonescimab for Advanced Pancreatic Cancer

HONG KONG, Sept. 22, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) has announced that the first patient has been dosed in its registrational Phase II study (AK130-202), evaluating AK130, a fully independently developed TIGIT/TGF-β bifunctional antibody fusion protein, in combination with ivonescimab ...

2025-09-22 14:51 1650

DIGITIMES ASIA Research Insights: Humanoid robots are coming, but hardware may decide how fast

TAIPEI, Sept. 22, 2025 /PRNewswire/ -- Nvidia's framing of the next AI wave as "physical AI" has fueled investor and industry excitement around humanoid robots, accelerating development. But according to a DIGITIMES report, 2025: The first year of humanoid robots — Global market trends and key te...

2025-09-22 14:22 1376

Wholesale Platform SUPER DELIVERY to Host Special Promotion Showcasing Matcha Culture of Japan Until October 7, 2025

TOKYO, Sept. 22, 2025 /PRNewswire/ -- RACCOON COMMERCE, Inc., operator of the wholesale and sourcing platform SUPER DELIVERY, is running a special promotion introducing Japanese matcha untilOctober 7, 2025. This promotion offers a discount for buyers in bothJapan and overseas, celebrating the glo...

2025-09-22 14:00 1514

Xinhua Silk Road: Dehua International Porcelain Culture Week opened to showcase charm of China's white porcelain to world

BEIJING, Sept. 21, 2025 /PRNewswire/ -- The 2025 Dehua International Porcelain Culture Week kicked off on Friday in Dehua County of Quanzhou City in southeast China's Fujian Province. The event featured 26 supporting activities, including thematic exhibitions and skill exchanges, comprehensively s...

2025-09-22 09:26 1943

Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy

-          The gastrointestinal (GI) tolerability of ASC47 in combination with semaglutide was significantly better than placebo in combination with semaglutide (semaglutide monotherapy). The incidence of vomiting was 6.7% in ASC47 in combinationwith semaglutide group compared to 57.1% in the sem...

2025-09-22 08:10 1774